5/28/2014 10:09:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today recognizes World MS Day, an initiative developed by the Multiple Sclerosis International Federation (MSIF) to raise awareness of MS and its impact on the lives of more than two million people around the world. With two differentiated MS therapies and a research pipeline focused on innovative approaches to treating the disease, Genzyme has a long-term commitment to the MS community.
Help employers find you! Check out all the jobs and post your resume.
comments powered by